MLYS: Mineralys Therapeutics, Inc. Stock

by  •  • Comments Off on MLYS: Mineralys Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 1,016.73
Enterprise Value ($M) 851.73
Book Value ($M) 341.56
Book Value / Share 5.24
Price / Book 2.98
NCAV ($M) 341.12
NCAV / Share 5.26
Price / NCAV 2.98

Profitability (mra)
Return on Invested Capital (ROIC) -0.55
Return on Assets (ROA) -0.54
Return on Equity (ROE) -0.57

Liquidity (mrq)
Quick Ratio 26.48
Current Ratio 26.48

Balance Sheet (mrq) ($M)
Current Assets 354.51
Assets 354.94
Liabilities 13.39
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -192.40
Net Income -177.81

Cash Flow Statement (mra) ($M)
Cash From Operations -166.31
Cash from Investing 114.96
Cash from Financing 116.14

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
03-17 13D/A Ra Capital Management, L.p. 9.90 27.04
03-17 13D/A Samsara BioCapital, L.P. 9.10 12.65
02-14 13G/A Adams Street Partners Llc 2.30 -50.93
11-13 13G/A Catalys Pacific Fund, LP 17.40 -5.73
11-13 13G/A HBM Healthcare Investments (Cayman) Ltd. 4.50 0.00
11-13 13G/A TCG Crossover GP II, LLC 5.00 -22.45

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-05-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q
2025-02-12 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q
2024-08-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-30 99,701 450,478 22.13
2025-05-29 51,430 234,884 21.90
2025-05-28 33,607 284,296 11.82
2025-05-27 140,173 763,734 18.35

(click for more detail)

Similar Companies
MGNX – MacroGenics, Inc. MGTX – MeiraGTx Holdings plc
MIST – Milestone Pharmaceuticals Inc. MNMD – Mind Medicine (MindMed) Inc.
MRNA – Moderna, Inc.


Financial data and stock pages provided by
Fintel.io